Special Issue
Innovations in Biomedical Research and Clinical Medicine
Guest Editor: Editorial Board — Journal of Biomedical Research & Environmental Sciences
Submission
Covid-19 Research
Safety Profile of COVID-19 Vaccines: Retrospective Analysis of Short, Medium, and Long-Term Side Effects: The Military Hospital Experience – Read more Evaluating the Efficacy of Different SARS-Cov-2 Drug Targets Using the Topo-Geometrical Superposition Algorithm, Molecular Docking and Chemical Reactivity Frameworks – Read more Preventing COVID-19 Infection by Complementary Medicine and Oral Health – Read more Analysis of Body Temperature in Patients with Trauma Visiting a Local Emergency Medical Center during the SARS-CoV-2 Outbreak – Read more N95 Respirator Fit Testing Experience during the Pandemic at a Singapore Tertiary Health Institution: Streamlining Workflow and Improving Respirator Fit Rate – Read more COVID-19 is an Amplifier of Social Inequalities Structural Violence against Students with Special Learning Needs and Low Socio-Economic Status – Read more Interaction between Chronic Influenza and COVID-19: Novel Aspects of Immune System Combat – Read more Daily Life, Fear of COVID-19 and Social Support in the Older Adults in Home Isolation: A Cross-Sectional Study – Read more The Impact of COVID-19 Pandemic on Cardiovascular Diseases in Brazil – Read more Diversity of Non-Influenza Respiratory Viruses Associated with Influenza-Like Illness during 2009 pre and pandemic periods in Sao Paulo, Brazil, a Historical Overview – Read more Cardiovascular Complications of SARS-CoV-2 (COVID-19) in Adults – Read more Impact of COVID-19 Pandemic on the Development of Childrens Executive Functions Implications for School-Based Interventions – Read more The Impact of the COVID-19 Pandemic on Youth Education – Read more Association between Dietary Habits, Lifestyle and Migraine Attacks During Social Isolation in the COVID-19 Pandemic: A Systematic Review of Observational Studies – Read more The Brazilian Increase in Cases of Lung Cancer and COVID-19, Can They be related? – Read more The Possible Therapeutic Application of CO on COVID-19 – Read more Planetary View of COVID Impact vs. IQ & PISA Rank as National Level of Intelligence – Read more Electrophysiological Study in a Patient with Visual Deficit after Severe Coronavirus 2 Pneumonia – Read more A Presentation of Analyses of COVID-19 Vaccine Samples, Blood Samples, Urine Samples, Foot Bath Samples, Sitz Bath Samples, and Skin-Extract Samples – Read more Is Anosmia-Ageusia in COVID-19 Patients Associated with Neuro-Philic Virus Mutant and Mild Respiratory Involvement? – Read more
Home/ AI Policy

Artificial Intelligence (AI) Policy

JBRES policy on the use of AI tools in manuscript preparation, peer review, and editorial decision-making.

Policy Effective Date

This policy applies to all manuscripts submitted on or after 1 January 2025 and to all peer review activities from the same date. It aligns with COPE's position statement on AI in research and scholarly publishing.

AI Tools in Manuscript Preparation (Authors)

AI Cannot Be Listed as an Author

Artificial intelligence tools — including large language models such as ChatGPT, Gemini, Claude, Copilot, and similar systems — cannot be listed as authors on any manuscript submitted to JBRES. Authorship requires the ability to accept accountability for the work, to respond to queries, and to consent to publication. AI tools cannot fulfil these responsibilities.

Any attempt to list an AI tool as an author will result in the manuscript being returned without review.

Disclosure of AI Use is Mandatory

Authors who use AI tools in the preparation of their manuscript — for any purpose including writing assistance, grammar correction, language editing, figure creation, data analysis, literature summarisation, or code generation — must disclose this use. Non-disclosure is a breach of publication ethics and may result in rejection or retraction.

The disclosure must be included in one of the following locations:

  • Methods section — if AI was used in data collection, analysis, or experimental design
  • Acknowledgements section — if AI was used for writing assistance, editing, or translation

The disclosure statement should name the specific tool(s) used, the version or date accessed, and the purpose for which they were used. Example: "ChatGPT (OpenAI, GPT-4, accessed March 2025) was used to improve the clarity of the Discussion section. The authors reviewed and take full responsibility for all content."

Authors Remain Fully Responsible

The use of AI tools does not reduce authors' responsibility for the accuracy, originality, and integrity of their work. Authors must critically evaluate all AI-generated content before inclusion in a manuscript. Factual errors, hallucinations, unsupported claims, or fabricated references introduced via AI tools remain the authors' responsibility and may constitute research misconduct if not corrected.

Permitted and Restricted AI Uses

UseStatusDisclosure Required?
Grammar and spell checking✅ PermittedNo (routine language tools)
Language editing / paraphrasing✅ Permitted with disclosureYes
Literature search assistance✅ Permitted with disclosureYes
Drafting sections of the manuscript✅ Permitted with disclosureYes
Data analysis or statistical modelling✅ Permitted with disclosureYes
Figure or image generation✅ Permitted with disclosureYes
Listing AI as an author❌ Not permittedN/A
Using AI to fabricate data or references❌ MisconductN/A

AI Tools in Peer Review (Reviewers)

Reviewers are permitted to use AI tools solely to assist with grammar checking or language editing of their own review text. Reviewers must not:

  • Use AI tools to generate the substantive content of a review
  • Upload manuscript text to AI platforms — doing so breaches manuscript confidentiality
  • Rely on AI-generated assessments as a substitute for their own expert scientific judgment

The review submitted to JBRES must represent the reviewer's independent, expert evaluation. Reviews that appear to have been entirely AI-generated may be rejected and the reviewer removed from our database.

See the full Peer Review Policy for additional reviewer expectations.

AI in Editorial Decision-Making

JBRES editors may use AI tools for administrative support (e.g., checking for scope fit, formatting consistency) but all substantive editorial decisions — including acceptance, rejection, and reviewer selection — are made by qualified human editors exercising independent scientific judgment. No editorial decision is made solely by an automated system.

Policy Compliance

By submitting a manuscript to JBRES, all authors confirm that any use of AI tools has been disclosed in accordance with this policy. Discovered non-disclosure after submission or publication will be treated as a breach of our Publication Ethics Policy and may result in rejection, correction, or retraction and institutional notification, as appropriate.

This policy will be reviewed and updated periodically as AI technologies and community standards evolve. For questions, contact [email protected].

COPE Position on AI

This policy is informed by the Committee on Publication Ethics (COPE) position statement on AI and authorship. For further reading visit publicationethics.org.

Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rigorous double-blind review, CrossRef DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable